Oversigt over overlevelse, responsrate og tiden indtil progression hos SCLC- patienter, der er behandlet med oral HYCANTIN eller intravenøs HYCAMTIN
Summary of survival, response rate, and time to progression in SCLC patients treated with oral HYCAMTIN or intravenous HYCAMTIN